Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy

A new therapeutic approach of looking at the expression of glucose-regulated protein (GRP) 58 as an indication of cisplatin sensitivity may eradicate fruitless treatment and side effects in patients with cervical cancer. Thymoquinone, the bioactive compound in Nigella sativa, has been reported to ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafiza, Wan Abd Ghani Wan Nor, Latifah, Saiful Yazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132255/
https://www.ncbi.nlm.nih.gov/pubmed/25143744
http://dx.doi.org/10.2147/OTT.S62928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132255/
https://www.ncbi.nlm.nih.gov/pubmed/25143744
http://dx.doi.org/10.2147/OTT.S62928

Ejemplares similares